Literature DB >> 3085838

Recurrence of focal glomerulosclerosis despite cyclosporin treatment after renal transplantation.

Y Pirson, J P Squifflet, E Marbaix, G P Alexandre, C van Ypersele de Strihou.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3085838      PMCID： PMC1340340          DOI： 10.1136/bmj.292.6531.1336

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  3 in total

1.  Reduction of urinary protein and prostaglandin E2 excretion in the nephrotic syndrome by non-steroidal anti-inflammatory drugs.

Authors:  R Vriesendorp; D de Zeeuw; P E de Jong; A J Donker; J J Pratt; G K van der Hem
Journal:  Clin Nephrol       Date:  1986-02       Impact factor: 0.975

2.  Recurrence of nephrotic syndrome during cyclosporin treatment after renal transplantation.

Authors:  A J Voets; A J Hoitsma; R A Koene
Journal:  Lancet       Date:  1986-02-01       Impact factor: 79.321

3.  Meclofenamate treatment of recurrent idiopathic nephrotic syndrome with focal segmental glomerulosclerosis after renal transplantation.

Authors:  V E Torres; J A Velosa; K E Holley; P P Frohnert; H Zincke; S Sterioff
Journal:  Mayo Clin Proc       Date:  1984-03       Impact factor: 7.616
  3 in total
  2 in total

1.  Recurrence of focal segmental glomerulosclerosis in transplanted kidneys: analysis of incidence and risk factors in 59 allografts.

Authors:  P Senggutuvan; J S Cameron; R B Hartley; S Rigden; C Chantler; G Haycock; D G Williams; C Ogg; G Koffman
Journal:  Pediatr Nephrol       Date:  1990-01       Impact factor: 3.714

2.  Recurrent nephrotic syndrome after transplantation: early treatment with plasmaphaeresis and cyclophosphamide.

Authors:  P Cochat; A Kassir; S Colon; C Glastre; B Tourniaire; B Parchoux; X Martin; L David
Journal:  Pediatr Nephrol       Date:  1993-02       Impact factor: 3.714
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.